Save
Meet the surgeon: Surgical Site Complications in GO
ESGO eAcademy, Malak Moubarak, 4193921
Tumour Board Webinar: Out of the box cases: Common tumours with an unusual course of disease
ESGO eAcademy, Faculty / Presenters, 4194129
ESGO Guidelines for the management of ovarian cancer - Update
ESGO eAcademy, Faculty / Presenters, 4194078
ESGO Cervical Cancer Resource - Stratified Guidelines
ESGO eAcademy, David Cibula, 4193922
Meet the Surgeon: Advanced Oncology Procedures by Robotic Approach
ESGO eAcademy, Faculty / Presenters, 4192292
Opportunistic Salpingectomy for the prevention of Ovarian Cancer: Evidence and Practice
ESGO eAcademy, Faculty / Presenters, 4194077
Surgical Mentorship Webinar: Trachelectomy
ESGO eAcademy, Faculty / Presenters, 4194128
Closing Ceremony
ESGO eAcademy, Faculty / Presenters, 4193902
Best Oral Session 4: Miscellaneous
ESGO eAcademy, Faculty / Presenters, 4193901
Treatment Planning and Perioperative Care: Myths, Facts and Practical Applications
ESGO eAcademy, Faculty / Presenters, 4193900
The Era of ADCs in Gynaecological Malignancies
ESGO eAcademy, Faculty / Presenters, 4193899
Grand Rounds 6: Endometrial Cancer
ESGO eAcademy, Faculty / Presenters, 4193898
Session 9: Advocacy Best Practice Sharing
ESGO eAcademy, Faculty / Presenters, 4193896
Out of the Box Procedures: The Challenge of Extended Resections at the Thorax, Abdominal and Pelvic Levels
ESGO eAcademy, Faculty / Presenters, 4193895
Grand Rounds 5: Endometrial Cancer
ESGO eAcademy, Faculty / Presenters, 4193894
Young Investigator Session
ESGO eAcademy, Faculty / Presenters, 4193893
Session 8: Clinical trials WORKSHOP
ESGO eAcademy, Faculty / Presenters, 4193892
Best Oral Session 3: Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4193889
Surgical Trends of the Future
ESGO eAcademy, Faculty / Presenters, 4193891
Intermediate-Risk Cervical Cancer - The Best Strategy?
ESGO eAcademy, Faculty / Presenters, 4193890
Video Session 4: Endometrial and Cervical Cancer
ESGO eAcademy, Faculty / Presenters, 4193886
Mini Oral Session 4: Endometrial Cancer
ESGO eAcademy, Faculty / Presenters, 4193885
Do We Really TRUST Radical Surgery in Advanced Ovarian Cancer?
ESGO eAcademy, Faculty / Presenters, 4193887
Hall D2 28-feb
ESGO eAcademy, Faculty / Presenters, 4193383
Endometrial Cancer Through the Clinical Lens: From Diagnosis to Decision
ESGO eAcademy, Faculty / Presenters, 4193884
Presidential and Awards Session
ESGO eAcademy, Faculty / Presenters, 4193882
AUD 10-11-12 28-feb
ESGO eAcademy, Faculty / Presenters, 4193386
Beyond Survival: Redefining Success Through Quality of Life in Gynaecological Oncology (organised by ENGAGe)
ESGO eAcademy, Faculty / Presenters, 4193881
Video Session 3: Miscellaneous
ESGO eAcademy, Faculty / Presenters, 4193879
New ESGO Ovarian Cancer Guidelines: Practical Applications through Tumour Board Simulation and Updated Care Algorithms - part II
ESGO eAcademy, Faculty / Presenters, 4193880
Video Session 2: Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4193878
Optimising the Patient-Physician Communication in a Shared Decision and Integrative Patient Care (organised by ENGAGe)
ESGO eAcademy, Faculty / Presenters, 4193877
Best Oral Session 2: Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4193876
Potential of AI in Theatre
ESGO eAcademy, Faculty / Presenters, 4193875
Mini Oral Session 3: Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4193874
Grand Rounds 4: Cervical Cancer
ESGO eAcademy, Faculty / Presenters, 4193873
Evolving Strategies in Platinum-Resistant Ovarian Cancer: Bridging Evidence, Regulation, and Clinical Care
ESGO eAcademy, Faculty / Presenters, 4193871
The Future of Ovarian Cancer: ADC and Beyond
ESGO eAcademy, Faculty / Presenters, 4193870
Updates on the Latest Clinical Trials that Have Changed Our Disease Management
ESGO eAcademy, Faculty / Presenters, 4193868
Best Three Minutes Presentations
ESGO eAcademy, Faculty / Presenters, 4193867
Grand Rounds 3: Vulvar Cancer
ESGO eAcademy, Faculty / Presenters, 4193866
Hall D2 27-feb
ESGO eAcademy, Faculty / Presenters, 4193382
PARP Inhibitors in Advanced Ovarian Cancer. Expanding Horizons: Transforming Outcomes and Supporting Patients to Move Forward
ESGO eAcademy, Faculty / Presenters, 4193865
Shaping the Future of Endometrial Cancer Management: Clinical Strategies and Study Updates
ESGO eAcademy, Faculty / Presenters, 4193864
HER2-Directed Therapies and Biomarker Testing in Gynaecological Cancers
ESGO eAcademy, Faculty / Presenters, 4193863
AUD 10-11-12 27-feb
ESGO eAcademy, Faculty / Presenters, 4193385
Is Selective Peritonectomy Equally Good Compared to Total Peritonectomy?
ESGO eAcademy, Faculty / Presenters, 4193860
Management of Rare Tumours
ESGO eAcademy, Faculty / Presenters, 4193861
Live Surgery Transmission
ESGO eAcademy, Faculty / Presenters, 4193855
Mini Oral Session 2: Cervical Cancer
ESGO eAcademy, Faculty / Presenters, 4193856
ESGO-ESTRO-ESP Guidelines on Endometrial Cancer and FIGO Staging in Light of Molecular Classification and Tumour Biology
ESGO eAcademy, Faculty / Presenters, 4193857
Opening Ceremony
ESGO eAcademy, Faculty / Presenters, 4193853
Biomarkers and Personalised Surgery as Advancements in Precision Oncology
ESGO eAcademy, Faculty / Presenters, 4193852
Complications & Symptom Support in Gynaecological Oncology: Profiles, Pitfalls, and Perspectives
ESGO eAcademy, Faculty / Presenters, 4193851
Grand Rounds 2: Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4193850
Mini Oral Session 1: Miscellaneous
ESGO eAcademy, Faculty / Presenters, 4193849
Pushing the Boundaries
ESGO eAcademy, Faculty / Presenters, 4193848
Grand Rounds 1: Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4193847
Management of Oligometastatic Recurrent Disease in Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 4193846
Should PARPi Be Included in the Treatment Options for pMMR Advanced/Recurrent Endometrial Cancer
ESGO eAcademy, Faculty / Presenters, 4193845
Video Session 1: Vaginal and Vulvar Cancer
ESGO eAcademy, Faculty / Presenters, 4193844
Best Oral Session 1: Endometrial and Cervical Cancer
ESGO eAcademy, Faculty / Presenters, 4193842
New ESGO Ovarian Cancer Guidelines: Practical Applications through Tumour Board Simulation and Updated Care Algorithms - part I
ESGO eAcademy, Faculty / Presenters, 4193841
Current and Future Landscape of Immunotherapy
ESGO eAcademy, Faculty / Presenters, 4193843
Optimizing Management in Platinum-Resistant Ovarian Cancer: From Early Diagnosis to Strategic and Targeted Treatment Sequencing
ESGO eAcademy, Faculty / Presenters, 4193840
Navigating the Course of Advanced Ovarian Cancer Maintenance Therapy with Current and Emerging Biomarkers
ESGO eAcademy, Faculty / Presenters, 4193839
Non-Chemo Combination Treatments in Gynaecological Cancers
ESGO eAcademy, Faculty / Presenters, 4193838
Hall D2 26-feb
ESGO eAcademy, Faculty / Presenters, 4193381
Hall D1 28-feb
ESGO eAcademy, Faculty / Presenters, 4193380
Hall D1 27-feb
ESGO eAcademy, Faculty / Presenters, 4193379
Hall D1 26-feb
ESGO eAcademy, Faculty / Presenters, 4193378
AUD 10-11-12 26-feb
ESGO eAcademy, Faculty / Presenters, 4193384
ESGO 2026 - Congress invitation
ESGO eAcademy, Faculty / Presenter(s), 4168940
Submit your video
ESGO eAcademy, Faculty / Presenters, 4194264
Patient Advocate
ESGO eAcademy, Faculty / Presenter(s), 4194074
Vaginal & Vulvar cancer
ESGO eAcademy, Faculty / Presenter(s), 4194073
Ovarian cancer
ESGO eAcademy, Faculty / Presenter(s), 4194072
Endometrial cancer
ESGO eAcademy, Faculty / Presenter(s), 4194071
Cervical cancer
ESGO eAcademy, Faculty / Presenter(s), 4194070
Meet the Surgeon: Urinary Fistula after Surgery
ESGO eAcademy, Faculty / Presenters, 4192291
Liver metastasis resection complicated by right hepatic vein injury: control and repair
ESGO eAcademy, Faculty / Presenters, 4193415
ESGO-INCIP Guidelines for the management of patients with gynaecological cancers during pregnancy
ESGO eAcademy, Faculty / Presenters, 4188283
Phenix Trial Presentation
ESGO eAcademy, Faculty / Presenter(s), 4193446
Access
ESGO eAcademy, Faculty / Presenter(s), 4192925
Colposcopy Uncovered: Past, Present, and Future in Cervical Cancer Prevention and Innovation
ESGO eAcademy, Faculty / Presenters, 4192760
Meet the surgeon: Biggest Achievements in Surgery – Personalized Surgical Management
ESGO eAcademy, Faculty / Presenters, 4174355
ASYGO - ENYGO 1st Joint Webinar: Training and Surgical Educatuion in Gyneacologic Oncology
ESGO eAcademy, Faculty / Presenters, 4194178
Challenges in biomarker-driven treatment approaches
ESGO eAcademy, Faculty / Presenter(s), 4192723
Biomarker-driven clinical approaches beyond molecular subgroups
ESGO eAcademy, Faculty / Presenter(s), 4192722
None-MMRd: NSMP, the biggest and least specific?
ESGO eAcademy, Faculty / Presenter(s), 4192721
None-MMRd: p53 abnormal, the worst
ESGO eAcademy, Faculty / Presenter(s), 4192720
None-MMRd: POLEmut, the best
ESGO eAcademy, Faculty / Presenter(s), 4192719
MMRd, the most clear molecular subgroup?
ESGO eAcademy, Faculty / Presenter(s), 4192718
Risk group stratification (including FIGO 2023 staging)
ESGO eAcademy, Faculty / Presenter(s), 4192717
The hereditary endometrial cancer - Lynch syndrome
ESGO eAcademy, Faculty / Presenter(s), 4192716
Integrating it all: AI and machine learning in endometrial carcinoma
ESGO eAcademy, Faculty / Presenter(s), 4192715
“Synchronous” tumours: are they synchronous?
ESGO eAcademy, Faculty / Presenter(s), 4192714
LVSI: no/focal/substantial. How to determine, to cluster und to guide treatment? Implications according to ESGO-ESTRO-ESP GLs
ESGO eAcademy, Faculty / Presenter(s), 4192713
LVSI: no/focal/substantial. How to determine, to cluster und to guide treatment? The pathological point of view
ESGO eAcademy, Faculty / Presenter(s), 4192712
LVSI: no/focal/substantial. How to determine, to cluster und to guide treatment? The clinical experience
ESGO eAcademy, Faculty / Presenter(s), 4192711

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings